Literature DB >> 3757939

Effect of carbamazepine on dopamine release and reuptake in rat striatal slices.

H M Barros, S Braz, J R Leite.   

Abstract

Carbamazepine has been shown to enhance dopaminergic agonist behavioral effects, but not to displace [3H]spiroperidol binding. To verify if carbamazepine acts presynaptically on dopaminergic neurons, reuptake and release of [3H]dopamine were measured in rat striatal slices in vitro. It was observed that carbamazepine blocked 20% of the reuptake of [3H]dopamine, while cocaine blocked 82% of the reuptake, compared with control. Carbamazepine released 62% and tyramine released 92% of the accumulated [3H]dopamine, compared with control. It was concluded that carbamazepine acts presynaptically on striatal neurons, mainly through enhancement of dopamine release. This finding can be related to some behavioral effects described for carbamazepine; however, the importance of its effects in epileptic and manic-depressive patients remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3757939     DOI: 10.1111/j.1528-1157.1986.tb03579.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

1.  Effects of carbamazepine on dopamine function in rodents.

Authors:  M Elphick
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  The effects of carbamazepine on two animal models of depression.

Authors:  H M Barros; J R Leite
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

Authors:  António F Ambrósio; Patrício Soares-Da-Silva; Caetana M Carvalho; Arsélio P Carvalho
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

4.  Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence.

Authors:  I D Montoya; F R Levin; P J Fudala; D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1995-06       Impact factor: 4.492

5.  Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine.

Authors:  H Zangrossi; J R Leite; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 6.  Management of the negative symptoms of schizophrenia: new treatment options.

Authors:  Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats.

Authors:  Opeyemi Samson Osuntokun; Ademola Adeniyi Babatunde; Gbola Olayiwola; Tope Gafar Atere; Olayemi Olutobi Oladokun; Kabiru Isola Adedokun
Journal:  Toxicol Rep       Date:  2021-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.